SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-018935
Filing Date
2021-08-06
Accepted
2021-08-06 17:29:06
Documents
57
Period of Report
2021-08-03
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 68787
2 ex3-1.htm EX-3.1 8970
3 ex99-1.htm EX-99.1 23957
4 ex99-2.htm EX-99.2 36517
5 ex99-3.htm EX-99.3 186988
6 ex99-2_001.jpg GRAPHIC 31696
7 ex99-3_001.jpg GRAPHIC 6844
8 ex99-2_002.jpg GRAPHIC 96189
9 ex99-2_003.jpg GRAPHIC 67396
10 ex99-2_004.jpg GRAPHIC 59902
11 ex99-2_005.jpg GRAPHIC 39661
12 ex99-2_006.jpg GRAPHIC 53619
13 ex99-2_007.jpg GRAPHIC 62308
14 ex99-2_008.jpg GRAPHIC 71011
15 ex99-2_009.jpg GRAPHIC 80082
16 ex99-2_010.jpg GRAPHIC 73159
17 ex99-2_011.jpg GRAPHIC 67823
18 ex99-2_012.jpg GRAPHIC 48691
19 ex99-2_013.jpg GRAPHIC 48077
20 ex99-2_014.jpg GRAPHIC 67465
21 ex99-2_015.jpg GRAPHIC 65918
22 ex99-2_016.jpg GRAPHIC 65705
23 ex99-2_017.jpg GRAPHIC 58708
24 ex99-2_018.jpg GRAPHIC 74899
25 ex99-2_019.jpg GRAPHIC 54942
26 ex99-2_020.jpg GRAPHIC 56273
27 ex99-2_021.jpg GRAPHIC 77796
28 ex99-2_022.jpg GRAPHIC 58612
29 ex99-2_023.jpg GRAPHIC 53703
30 ex99-2_024.jpg GRAPHIC 57930
31 ex99-2_025.jpg GRAPHIC 22452
32 ex99-2_026.jpg GRAPHIC 22529
33 ex99-2_027.jpg GRAPHIC 69938
34 ex99-2_028.jpg GRAPHIC 62281
35 ex99-2_029.jpg GRAPHIC 65291
36 ex99-2_030.jpg GRAPHIC 50441
37 ex99-2_031.jpg GRAPHIC 41375
38 ex99-2_032.jpg GRAPHIC 48266
39 ex99-2_033.jpg GRAPHIC 60056
40 ex99-2_034.jpg GRAPHIC 61520
41 ex99-2_035.jpg GRAPHIC 56360
42 ex99-2_036.jpg GRAPHIC 59805
43 ex99-2_037.jpg GRAPHIC 59519
44 ex99-2_038.jpg GRAPHIC 57563
45 ex99-2_039.jpg GRAPHIC 31273
46 ex99-2_040.jpg GRAPHIC 51105
  Complete submission text file 0001493152-21-018935.txt   3736508

Data Files

Seq Description Document Type Size
47 XBRL SCHEMA FILE indp-20210803.xsd EX-101.SCH 3021
48 XBRL LABEL FILE indp-20210803_lab.xml EX-101.LAB 34239
49 XBRL PRESENTATION FILE indp-20210803_pre.xml EX-101.PRE 22356
50 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3649
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 211153960
SIC: 2834 Pharmaceutical Preparations